Abstract
In my other chapter in this book (Biological vs. Psychological Perspectives on Anxiety Disorder) I presented a Table 1 listing some proposed etiologies of anxiety disorders and corresponding treatments. It would be wrong to infer from this table that the postulated causes were discovered first and the treatments followed as logical deductions. In many cases, a cause was inferred from the presumed mechanism of action of some treatment believed to be effective against anxiety. Treatments of mental disorders have always seemed more rooted in reality than theories of mental disorders. It is instructive, therefore, to examine outcome studies of purportedly successful biological and psychological treatments of anxiety disorders in order to determine how solid the factual bases of those inferences really are.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agras, W.S., Teich, M.J., Taylor, C.B., Roth, W.T., and Brouillard, M.E. (1990). Imipramine and exposure therapy in agoraphobia: Untangling the actions and interactions. Submitted for publication.
Ballenger, J.C., Burrows, G.D., DuPont, R.L., Lesser, I.M., Noyes, R, Jr., Pecknold, J.C, Rifkin, A., and Swinson, R.P. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413–422.
Clark, D.B., Taylor, C.B., Roth, W.T., and Agras, W.S. (1990) Surreptitious antianxiety medication use in a panic disorder study. American Journal of Psychiatry, 147, 507–509.
Cohen, S.D., Monteiro, W., and Marks, I.M. (1984). Two-year follow-up of agoraphobics after exposure and imipramine. British Journal of Psychiatry, 144, 276–281.
Craske, M.G., Sanderson, W.C., and Barlow, D.H. (1987). How do desynchronous response systems relate to the treatment of agoraphobia: A follow-up evaluation. Behaviour Research and Therapy, 25, 117–122.
Dilsaver, S.C., and Coffman, J.A. (1989). Cholinergic hypothesis of depression: A reappraisal. Journal of Clinical Psychopharmacology, 9, 173–179.
Fiegenbaum, W. (1988). Long-term efficacy of ungraded versus graded massed exposure in agoraphobics. In I. Hand and H.-U. Wittchen (Eds.), Panic and Phobias 2. Treatments and Variables affecting Course and Outcome (pp. 83–88). Berlin: Springer-Verlag.
Fisher, S., and Greenberg, R.P. (1989). A second opinion: Rethinking the claims of biological psychiatry. In S. Fisher and R.P. Greenberg (Eds.), The Limits of Biological Treatments for Psychological Distress. Comparisons with Psychotherapy and Placebo (pp. 309–336). Hillsdale, NJ: Erlbaum.
Frank, J.D. (1961). Persuasion and Healing. A Comparative Study of Psychotherapy. Baltimore: Johns Hopkins Press.
Greenberg, R.P, and Fisher, S. (1989). Examining antidepressant effectiveness: Findings, ambiguities, and some vexing puzzles. In S. Fisher and R.P. Greenberg (Eds.), The Limits of Biological Treatments for Psychological Distress. Comparisons with Psychotherapy and Placebo (pp. 1–37). Hillsdale, NJ: Erlbaum.
Klein, D.F. (1980) Anxiety reconceptualized. Comprehensive Psychiatry, 21, 411–427.
Klein, D.F., Zitrin, C.M., Woerner, M.G., Ross, D.C. (1983). Treatment of Phobias. II. Behavior therapy and supportive psychotherapy: Are there any specific ingredients? Archives of General Psychiatry, 40, 139–145.
Klerman, G.I., Ballenger, J.C., Burrows, G.D., DuPont, R.L., Noyes, R., Jr., Pecknold, J.C., Rofkin, A., Rubin, R.T., and Swinson, R.P. (1989) In reply. [to Marks et al. (1989)]. Archives of General Psychiatry, 46, 670–672.
Margraf, J. (1989). Beiträge zur Diagnostik, Theorie und Therapie des Paniksyndroms. Habilitationsschrift, Fachbereich Psychologie der Philipps-Universität Marburg. Submitted 1989.
Margraf, J., Ehlers, A., and Roth, W.T. (1986a). Panic attacks: Theoretical models ar 1 empirical evidence. In I. Hand and H.-U. Wittchen (Eds.), Panic and Phobias (pp. 31–43), Berlin: Springerf.
Margraf, J., Ehlers, A., and Roth, W.T. (1986b). Biological models of panic disorder and agoraphobia: A review. Behaviour Research and Therapy, 24, 553–567.
Margraf, J., Ehlers, A., and Roth, W.T. (1986c) Sodium lactate infusions and panic attacks: A review and critique. Psychosomatic Medicine, 48, 23–51.
Margraf, J., Ehlers, A., and Roth, W.T. (1988) Mitral valve prolapse and panic disorder: A review of their relationship. Psychosomatic Medicine, 50, 93–113.
Marks, I.M. (1987). Fears, Phobias, and Rituals. Panic, Anxiety, and Their Disorders. Oxford: Oxford University Press.
Marks, I.M., De Albuquerque, A., Cottraux, J., Gentil, V., Greist, J., Hand, L, Liberman, R.L., Relvas, J.S., Tobena, A., Tyrer, P, and Wittchen, H.-U. (1989). The ‘efficacy’ of alprazolam in panic disorder and agoraphobia: A critique of recent reports. Letter to the Editor. Archives of General Psychiatry, 46, 668–670.
Marks, I.M., Gray, S., Cohen, D., Hill, R., Mawson, D., Ramm, E., and Stem, R. (1983). Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Archives of General Psychiatry, 40, 153–162.
Mavissakalian, M. (1988). The mutually potentiating effects of imipramine and exposure in agoraphobia. In I. Hand, and H.-U. Wittchen. Panic and Phobias 2. Treatments and Variables affecting Course and Outcome (pp. 36–43). Berlin: Springer-Verlag.
Mavissakalian, M., and Michelson, L. (1982). Agoraphobia: Behavioral and pharmacological treatments, preliminary outcome, and process findings. Psychopharmacology Bulletin, 18, 91–103.
Mavissakalian, M., and Michelson, L. (1986). Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. Journal of Clinical Psychiatry, 143, 1106–1112.
Mavissakalian, M., Michelson, L., and Dealy, R.S. (1983). Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice. British Journal of Psychiatry, 143, 348–355.
Mellman, T.A., and Uhde, T.W. (1989). Electroencephalographic sleep in panic disorder. Archives of General Psychiatry, 46, 178–184.
Overton, D.A. (1966). State-dependent learning produced by depressant and atropine-like drugs. Psychopharmacologia, 23, 373–385.
Pecknold, J.C., Swinson, R.P., Kuch, K., and Lewis, C.P. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. HI. Discontinuation effects. Archives of General Psychiatry, 45, 429–436.
Rachman, S., Craske, M., Tallman, K., and Solyom, C. (1986). Does escape behavior strengthen agoraphobic avoidance? A replication. Behavior Therapy, 17, 366–384.
Telch, M.J., Agras, W.S., Taylor, C.B., Roth, W.T., and Gallen, C.C (1985). Combined pharmacological and behavioral treatment for agoraphobia. Behaviour Research and Therapy, 25, 325–335.
Vermilyea, J.A., Boice, R., and Barlow, D.H. (1984). Rachman and Hodgson (1974) a decade later: How do desynchronous response systems relate to the treatment of agoraphobia? Behaviour Research and Therapy, 22, 615–621.
Weissman, M.M., Klerman, G.L., Markowitz, J.S., and Ouellette, R. (1989). Suicidal ideation and suicide attempts in panic disorder and attacks. New England Journal of Medicine, 321, 1209–1214.
Zitrin, C.M., Klein, D.F., and Woemer, M.G. (1980). Treatment of agoraphobia with group exposure in vivo and Imipramine. Archives of General Psychiatry, 37, 63–72.
Zitrin, C.M., Klein, D.G., Woemer, M.G., and Ross, D.C. (1983). Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. Archives of General Psychiatry, 40, 125–138.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Roth, W.T. (1991). Biological vs. Psychological Treatments of Anxiety Disorders. In: Ehlers, A., Fiegenbaum, W., Florin, I., Margraf, J. (eds) Perspectives and Promises of Clinical Psychology. Applied Clinical Psychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3674-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3674-5_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-3676-9
Online ISBN: 978-1-4899-3674-5
eBook Packages: Springer Book Archive